Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.

Koh, Jeffery Wei Heng; Ng, Cheng Han; Tay, Sen Hee

Koh, Jeffery Wei Heng; Ng, Cheng Han; Tay, Sen Hee.

Koh JWH; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.
Ng CH; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Tay SH; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Lupus ; 29(14): 1845-1853, 2020 Dec.

Article en En | MEDLINE | ID: mdl-32960720

Asunto(s)

Anticuerpos Monoclonales Humanizados/administración & dosificación; Lupus Eritematoso Sistémico/tratamiento farmacológico; Anticuerpos Monoclonales Humanizados/efectos adversos; Productos Biológicos; Humanos; Interferón Tipo I/antagonistas & inhibidores; Ensayos Clínicos Controlados Aleatorios como Asunto; Receptor de Interferón alfa y beta/antagonistas & inhibidores

Palabras clave

Systemic lupus erythematosus; anifrolumab; interferon type I; meta-analysis

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Lupus Eritematoso Sistémico Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google